viewInnovaDerma PLC

InnovaDerma PLC - Directorate Change

RNS Number : 2022V
InnovaDerma PLC
05 August 2020

 LEI: 213800WRAP6W8VDL6B38

InnovaDerma PLC

("InnovaDerma" or the "Group")

Directorate Changes

InnovaDerma (LSE: IDP), a UK developer of beauty, personal care and life science products, today announces that Kieran Callan has stepped down as Chief Executive Officer and as a Director of the Group with immediate effect, by mutual agreement with the Board. Kieran will continue to be available until 31 August 2020 for any handover and to assist the Board in any relevant matters. 

The Group has commenced a formal process for the identification and appointment of a new CEO and will provide updates, as appropriate, in due course. In the meantime, Joe Bayer will serve as Interim CEO as well as Executive Chairman.

In addition, InnovaDerma announces that Warren Dockary, currently Group Financial Controller has been appointed as Chief Financial Officer and will report to the Board. Warren is a Chartered Accountant and has been with the business since November 2018. He is a graduate from Massey University in New Zealand and has held senior finance roles in the consumer products and logistics industries.

On behalf of the Board, Executive Chairman and Interim CEO, Joe Bayer said:

"The Board and I would like to thank Kieran for his contribution and strategic insight over the past three years, first as a Non-executive Director then as a CEO when he was appointed in 2018. InnovaDerma is a strong business with a clear strategy, underpinned by a multi-channel approach with ecommerce being the most important factor for future growth.  We have agreed that now is the right time for a change of leadership in the Group to implement that strategy and maximise the opportunities that lie ahead.


"We are pleased to have appointed Warren to the role of Chief Financial Officer, and it is particularly pleasing to make this very well-deserved promotion from within the business.  Warren has deep knowledge of the business and his appointment strengthens our senior management team."

Kieran Callan, outgoing CEO, said:

"It is a privilege to have worked at InnovaDerma and I leave behind an immensely talented team and a business which is resilient and delivering upon its strategic aims. We have developed our customer-centric and digital-led strategy that will guide the future of the business over the coming years and I feel it is the right time to step down and seek new challenges elsewhere.  The Company is strongly positioned and I look forward to see it going from strength to strength."

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Further enquiries



Joe Bayer



+61 417 870 743


finnCap Ltd

Geoff Nash/Kate Bannatyne

Alice Lane/Manasa Patil - Corporate Broking


+44 (0)207 220 0500


TB Cardew

Shan Shan Willenbrock/Tom Allison

Olivia Rosser


+ 44 (0)20 7930 0777

[email protected]



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

Quick facts: InnovaDerma PLC

Price: 53.4

Market: LSE
Market Cap: £7.74 m

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


Morning report: FTSE flies as HSBC jumps and Trump tax evasion accusation...

FTSE 100 made a decent start to the week buoyed by M&A activity and good rises by markets in Asia. The blue chip index was up 90 at 5,933. Donald Trump paid just US$750 in tax in 2016 and 2017 and none at all for a decade, according to The New York Times. Trump, who said the report was...

3 weeks, 1 day ago

3 min read